project . 2019 - 2019 . Closed

ABOPEN

FIRST INSTANT, OFF-THE-LAB AND USER-FRIENDLY BLOOD GROUPING TEST

Open Access mandate for Publications European Commission

Funder: European CommissionProject code: 868361 Call for proposal: H2020-SMEInst-2018-2020-1
Funded under: H2020 | SME-1 Overall Budget: 71,429 EURFunder Contribution: 50,000 EUR
Status: Closed
Start Date
01 May 2019
End Date
31 Aug 2019
Detailed project information (CORDIS)

Open Access mandate
Research Data: No

Link this project to...

Research outcomes
Deposit your research

Select content type to share

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=corda__h2020::09ef5cc1defd8a6c7bab88b74f1d333c&type=results"></script>');
-->
</script>

For further information contact us at helpdesk@openaire.eu

Download report

Select content type report to download

Summary
Publications
Research Data
Software
Other Research

Description

Despite being eradicated from the developed world, the Rhesus Disease or HDFN (Hemolytic Disease of the Fetus and Newborn), a disease where the immune system from the mother attacks the red blood cells from their babies, still kills 141,000 children and mothers in developing regions every year. Deaths that could be easily prevented by screening pregnant women for their RhD factor type. Although 15% of RhD(-) women are at risk, 220 million women in developing countries should be tested, since the majority do not know their RhD factor type. At Eldon Biologicals AS (a Danish company created in 2002), we are a profitable company that has already sold millions of Eld...

Partners

ELDON BIOLOGICALS A/S

Summary

Description

Partners

ELDON BIOLOGICALS A/S

Any information missing or wrong?Report an Issue